Valerie Odegard is President and CSO of Silverback Therapeutics, Inc.. Currently has a direct ownership of 61,639 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on May 02, 2022, when has been sold 45,233 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.6K
0% 3M change
0% 12M change
Total Value Held $0

Valerie Odegard Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 02 2022
BUY
Grant, award, or other acquisition
-
45,233 Added 42.32%
61,639 Common Stock
Feb 01 2022
BUY
Grant, award, or other acquisition
-
16,406 Added 50.0%
16,406 Common Stock
VO

Valerie Odegard

President and CSO
Seattle, WA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX